ELSEVIRE Global Medical News
Search Elsevier Global Medical News
Clinical Neurology News
 
 
  Diamond Headache   American Academy of Neurology   American Headache Society
 
This news site is not sanctioned by, nor part of, the Diamond Headache Foundation, The American Academy of Neurology OR The American Headache Society.
News covering selected sessions related to migraine from 2008 medical conferences.
Diamond Headache Clinic Research and Educational Foundation Annual Research Summit Scottsdale, Arizona February 18-22, 2008
 
 
  Gender Based issues in Epilepsy Management
 
  Migraine Preventative therapies
 
  Distinquising Between Migraine and Tension Headache
 
Perimenopuasl Issues and Migraine
 
  Migraine Headache-Diagnosis and Treatment
 
  Biology of Migraine and other Headaches
 
  Exertional Headache: Uncommon, Usually Benign,
but Worrisome
 
  Vertigo, Dizziness Often Reported With Migraine, but Are They Related?
 
  Central Sensitization and Cutaneous Allodynia Implication on Migraine Treatment
 
  Expect the Unexpected When Headache Occurs in Older Patients
 
  Often Implicated, the Eye Rarely Causes Headache
 
Defining the Complicated Migraine
 
Studies Reveal Migraine with Aura is a Risk Factor for Heart Disease
 
Hormonal Therapies for Migraine: Risks vs Benefits
 
Menstrual Migraines
 
Cluster Headache
 
Emergency Department Treatment of Headache
 
 
  Cluster Headache Often Mistaken for Nasal, Sinus, or Ocular Condition  
BY DON SCHRADER
Contributing Writer
SCOTTSDALE, ARIZ. (ECCC)— Nasal and ocular symptoms associated with cluster headache can easily lead a clinician down the wrong diagnostic pathway, said Dr. Frederick G. Freitag on February 21 at a headache course sponsored by the Diamond Headache Clinic Research and Education Foundation.
Droopy eyelid, tearing, nasal congestion, and even perfuse rhinorrhea can occur in patients with cluster headache.
“This constellation of nasal-eye symptoms plays a role, I believe, in some of the misdiagnosis and maldiagnosis of cluster headache, particularly when those symptoms are combined with the seasonal occurrence that is typical of cluster headache,” said Dr. Freitag, associate director of the Diamond Headache Clinic in Chicago.
“If a patient with headache presents in the fall of the year and complains of stuffiness, the nose runs, and the eyes are red. A physician could understandably think ‘This could be allergies or sinus problems.’”
The misdiangosis can lead to inappropriate treatment that ironically may provide some transient benefits, Dr. Freitag continued. Because decongestants constrict blood vessels, they relieve the headache and associated symptoms for awhile. Then the headaches resume and the patient continues with misdiagnosis.
“The point is that we need to pay attention to the whole constellation of symptoms and perform a thorough history and physical examination,” said Dr. Freitag.
The ocular signs and symptoms of cluster headache can include eyelid and pupil symptoms that mimic Horner’s syndrome, he added. The eye on the same side of the head affected by the headache pain may become droopy. The headache pain may concentrate in the orbital area around the eye, and some patients complain of residual soreness in and around the orbital area after resolution of the headache.
The epidemiology of cluster headache has changed in recent years. Once considered a condition affecting men almost exclusively, cluster headache has begun to occur in more women, said Dr. Freitag. Multiple medical and nonmedical explanations have been offered for the increased number of women affected by the condition, but better recognition and diagnosis of cluster headache by clinicians probably has played a major role, he added.
Other features of the condition largely remain the same. Cluster headache tends to have an onset in a person’s late 20s or early 30s. Most patients have one or two cycles per year, lasting 2 to 3 months. Spontaneous remissions do occur and last an average of about 2 years, although a range of 2 months to 20 years has been reported.
Two common periods of onset are within the first 2 weeks before or after the summer and winter solstices, according to Dr. Freitag. In many patients, cluster headache has a circadian pattern of onset. Attacks often occur at night, especially near the end of a sleep cycle.
As opposed to the throbbing pain that typifies migraine, cluster headache involves localized pain that patients describe as a deep burning or boring sensation. Migrainous features, such as nausea and vomiting, are rarely seen in patients with cluster headache, although women present with these symptoms more often than men and are more likely to have coexistent migraine and cluster headache.
Patient behavior differs dramatically with cluster headache versus migraine. Whereas the migraine patient prefers the refuge of a bed in a darkened, quiet room, a patient with cluster headache exhibits agitation, including pacing, verbal outbursts, and threats to harm themselves or others.
“I have had patients who hit their head against a wall to try to get rid of the pain,” said Dr. Freitag.
In about 10% of patients, cluster headache evolves from an episodic to a chronic condition. Transition to chronic cluster headache is characterized by loss of circadian or circannual features, and rarely does a remission last longer than 2 weeks. Patients tend to be in pain continually, are often resistant to common therapies, and frequently develop tachyphylaxis to preventive treatments.
“Essentially, the remission periods end, and the headache cycle continues without interruption,” said Dr. Freitag. “Most patients have no remissions, but when remissions do occur, they are very brief.”
After cluster headache makes the transition to a chronic condition, the pain usually continues for a year or even longer before showing any signs of resolution. In some patients, a headache cycle may last a decade or longer.
Copyright 2008 Elsevier Custom Conference Coverage. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed. All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise, without the prior written permission of the copyright owner. No responsibility is assumed by the Publisher for any injury and/or damage to persons or property as a matter of products liability, through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, the Publisher recommends that independent verification of diagnoses and drug dosages should be made. Opinions expressed in this publication are those of the original authors and do not necessarily reflect those of the Publisher, the sponsor, or the editors. Elsevier assumes no liability for any material published herein.
 

Terms of Use                                    Privacy Policy                                    Contact Us

 
  Copyright ©2010 Elsevier/International Medical News Group
  5635 Fishers Lane, Suite 6000
Rockville, MD 20852
Rights reserved Clinical Neurology News Network